What is Cell Applications?
Established in 1994, Cell Applications, Inc. operates as a premier provider of primary cells, specialized media, and tissue engineering solutions. By maintaining rigorous manufacturing standards under FDA 21 CFR Part 820 and cGMP guidelines, the company serves as a foundational partner for both academic research institutions and large-scale pharmaceutical drug discovery programs. Their product portfolio, which includes stem cells and three-dimensional cell models, is engineered to provide physiologically relevant data, effectively bridging the gap between basic laboratory research and clinical application. The company's commitment to quality control and technical support has made its products a staple in high-impact scientific literature, including research recognized by Nobel Prize committees.
How much funding has Cell Applications raised?
Cell Applications has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Cell Applications
PPP
Public-Private Partnership
What's next for Cell Applications?
With this latest round of financing, Cell Applications is well-positioned to accelerate its expansion into advanced therapeutic development and high-throughput drug screening markets. The strategic deployment of this capital will likely focus on enhancing their proprietary cell culture technologies and scaling manufacturing capacity to meet the increasing global demand for standardized, high-purity biological materials. As the industry shifts toward more complex 3D models and personalized medicine, Cell Applications is poised to leverage its deep technical expertise and established regulatory framework to maintain its competitive edge. Future growth will likely be driven by continued innovation in differentiation protocols and the expansion of their custom service offerings for global biopharma partners.
See full Cell Applications company page
